4D Molecular Therapeutics Announces FDA Clearance of IND Application for 4D-150 Genetic Medicine for the Treatment of Diabetic Macular Edema
4D Molecular Therapeutics Announces Updates on Clinical Pipeline and Additional Preclinical Programs